Search Results 1141-1150 of 15425 for alt

1. Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors, The PNeoVCA Study - Mayo Clinic

   REGISTRATION: Alanine aminotransferase (ALT) and aspartate transaminase (AST) =< 3 x ULN (=< 5 x ULN for patients with liver involvement) (obtained =< 14 days ...

2. Study Of Lurbinectedin In Combination With Doxorubicin Versus Doxorubicin Alone As First-line Treatment In Participants With Metastatic Leiomyosarcoma - Mayo Clinic

   Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 3.0 x upper limit of normal (ULN);. Total bilirubin ≤ ULN or direct bilirubin ≤ ULN ...

3. Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) - Mayo Clinic

   ... (ALT) \< 3.0 x upper limit of normal (ULN), and total bilirubin =\< 2.0 x ULN (or 5.0 x ULN if the participant has a history of Gilbert's disease) within 28 ...

4. A Study of MBG453 in Combination With Azacitidine and Venetoclax in AML Patients Unfit for Chemotherapy - Mayo Clinic

   AST and ALT ≤ 3 × upper limit of normal (ULN). Total bilirubin ≤ 3.0 × ULN (except in the setting of isolated Gilbert syndrome, in which case higher total ...

5. MDM2 Inhibitor AMG-232 and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma - Mayo Clinic

   SGOT (AST) or SGPT (ALT) < 2.5 x upper limit of normal (ULN) appropriate for age. Females of child-bearing potential must have a negative serum pregnancy ...

6. A Study Using Targeted Inhibitors to Treat Specific Tumor Mutations in Patients with Meningiomas - Mayo Clinic

   AST/ALT ≤ 2.5 x ULN; Fasting triglyceride ≤ 200 mg/dL,for patients with NF2 mutation; Fasting cholesterol ≤ 240 mg/dL,for patients with NF2 mutation ...

7. The children are watching — what can you tell them? - Mayo Clinic News Network

   She adds that providing context about the alt-right movement and where it originates can be an important piece to help older children understand the issue.

8. A Study to Evaluate the Effectiveness and Safety of P276-00 for Mantle Cell Lymphoma that has Returned and/or is Resistant to Treatment - Mayo Clinic

   Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) >3 × institutional upper limit of normal (ULN) (> 5 × institutional ULN if liver is ...

9. Oral Epalrestat Therapy in Pediatric Subjects With PMM2-CDG - Mayo Clinic

   Hypersensitivity to epalrestat. 4. Hepatic impairment defined as any one of the following: 1. AST/ALT > 5 x ULN in the 6 months prior to screening; 2 ...

10. Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

    AST (aspartate aminotransferase)/ALT (alanine aminotransferase) ≤ 5x ULN; PTT (Partial Thromboplastin Time) or aPTT (activated Partial Thromboplastin Time) ...